Redefining early allograft dysfunction in living donor liver transplantation: Towards adaptive, graft-specific, and AI-enabled models
journals.lww.com/lt/citation…
Tricuspid regurgitation predicts mortality after liver transplantation in patients with high MELD score: A retrospective cohort study
journals.lww.com/lt/abstract…
Safety, tolerability and efficacy of GLP-1 receptor agonists (GLP-1 RA) in the management of post-liver transplant weight gain: A multicenter, observational study
journals.lww.com/lt/abstract…
Redefining early allograft dysfunction in living donor liver transplantation: Towards adaptive, graft-specific, and AI-enabled models
journals.lww.com/lt/citation…
From our June newsletter: For patients with #cirrhosis, simpler tools such as ultrasound, bioelectrical impedance analysis, and anthropometry may offer a more accessible way to detect #sarcopenia.
Explore the full study in @LTxJournal: ow.ly/USXx50Z6Rb5
Material economic hardships are associated with second-year hospitalizations after pediatric liver transplantation: Results from the SOCIAL-Tx study
journals.lww.com/lt/abstract…
🎉 AASLD is excited to announce the 2026 Editorial Fellows for @HEP_Journal and @LTxJournal!
The 2026 Editorial Fellows will gain unique, hands-on experience in scholarly publishing and journal editorial leadership while working alongside experienced editors at two of the field’s leading hepatology journals.
Learn more: bit.ly/4ocpLgq.
⬇️ MOC opportunity
Reconditioning steatotic liver grafts: Advances in pharmacological defatting approaches for expanding the donor pool
journals.lww.com/lt/fulltext…
🔥HOT TOPIC
📙@LTxJournal
An international multicenter study provides the first real-world validation of TransMet trial criteria, showing that #livertransplantation for unresectable colorectal liver metastases delivers a meaningful survival benefit, approximately 22.5 additional months over chemotherapy, with outcomes closely mirroring trial data.
With robust methodology and clinically actionable insights, including key prognostic factors (e.g., KRAS mutation, tumor sidedness, CEA), these findings help inform patient selection and advance a highly debated area of transplant policy.
bit.ly/4sNI38b@prof_cillo@Vaital73@AlessandroRov19@Mohamma70696197@sara_lonardi1@FAucejo@pdline